Wellgistics Health (WGRX) CEO converts 100,000 warrants into shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Wellgistics Health, Inc. Chief Executive Officer Prashant Patel exercised compensation-related warrants into common stock. On June 22, 2026, he exercised warrants covering 100,000 shares of common stock at an exercise price of $0.005 per share, converting them into common shares.
The warrants were originally issued to him on March 31, 2026 in lieu of cash compensation. Following a reverse stock split effective May 26, 2026 and this warrant conversion, Patel now directly holds a total of 282,365 shares of Wellgistics common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
100,000 shares exercised/converted
Mixed
2 txns
Insider
Patel Prashant
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Warrant | 100,000 | $0.00 | -- |
| X | Common Stock | 100,000 | $0.005 | $500.00 |
Holdings After Transaction:
Warrant — 0 shares (Direct);
Common Stock — 282,365 shares (Direct)
Footnotes (1)
- Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person. Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants.
Key Figures
Common shares from exercise: 100,000 shares
Exercise price: $0.005 per share
Post-transaction holdings: 282,365 shares
+2 more
5 metrics
Common shares from exercise
100,000 shares
Common Stock acquired via warrant exercise on June 22, 2026
Exercise price
$0.005 per share
Exercise price of warrants converted into common stock
Post-transaction holdings
282,365 shares
Total Common Stock held directly by CEO after reverse split and conversion
Warrants exercised
100,000 warrants
Derivative position in Warrants converted into Common Stock
Warrant expiration
March 31, 2031
Original expiration date of the Warrants before full exercise
Key Terms
in-the-money derivative exercise, Warrants, in lieu of cash compensation, reverse stock split
4 terms
in-the-money derivative exercise financial
"transaction_action: in-the-money derivative exercise for Common Stock and Warrants"
Warrants financial
"Represents the conversion of warrants (the "Warrants") issued to the Reporting Person"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
in lieu of cash compensation financial
"Warrants issued to the Reporting Person on 3/31/2026 in lieu of cash compensation"
reverse stock split financial
"following the Issuer's reverse stock split, effective May 26, 2026"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
FAQ
What insider transaction did Wellgistics Health (WGRX) report for its CEO?
Wellgistics Health reported that CEO Prashant Patel exercised warrants for 100,000 shares of common stock at $0.005 per share. The warrants were compensation issued in lieu of cash, and the exercise converted them into additional common shares he now holds directly.
What were the terms of the warrants exercised by the Wellgistics (WGRX) CEO?
The warrants exercised by CEO Prashant Patel covered 100,000 underlying common shares with an exercise price of $0.005 per share. They were issued to him on March 31, 2026 as compensation in lieu of cash and were later fully converted into common stock.
How is the Wellgistics (WGRX) reverse stock split reflected in the CEO’s holdings?
The CEO’s post-transaction holdings of 282,365 common shares reflect the company’s reverse stock split effective May 26, 2026. This figure also incorporates the additional common stock issued when his 100,000-share warrant position was converted into common shares.